IDXX

IDEXX Laboratories
D

IDXX

Arincen86/100B

IDEXX Laboratories cash on hand 1991–2026

IDEXX Laboratories had 197.54M USD in cash and short-term investments on 30 September 2026, down 5.1% on a year before. At the end of fiscal year 2025 it had 180.07M USD.

Last updated 7 Nov 2026 · Next report 1 Feb 2027

Cash on hand

Growth

Fiscal yearPeriod endingCash on handGrowthTotal debtNet cash
Latest quarter30 Sept 2026197.54M-5.11%972.96M-775.43M
FY202531 Dec 2025180.07M-37.53%976.06M-795.99M
FY202431 Dec 2024288.27M-36.50%986.95M-698.68M
FY202331 Dec 2023453.93M+303.33%1.07B-613.42M
FY202231 Dec 2022112.55M-22.09%1.47B-1.36B
FY202131 Dec 2021144.45M-62.37%1.03B-886.56M
FY202031 Dec 2020383.93M+325.05%1.00B-619.32M
FY201931 Dec 201990.33M-27.04%1.07B-980.10M
FY201831 Dec 2018123.79M-73.77%1.00B-876.49M
FY201731 Dec 2017471.93M+20.44%1.26B-789.15M
FY201631 Dec 2016391.85M+14.38%1.20B-812.26M
FY201531 Dec 2015342.59M+6.22%1.17B-827.50M
FY201431 Dec 2014322.54M+15.58%899.00M-576.46M
FY201331 Dec 2013279.06M+24.59%428.39M-149.34M
FY201231 Dec 2012223.99M+21.80%214.50M9.49M
FY201131 Dec 2011183.90M+17.19%246.42M-62.52M
FY201031 Dec 2010156.92M+47.02%133.28M23.64M
FY200931 Dec 2009106.73M+35.32%123.88M-17.16M
FY200831 Dec 200878.87M+30.66%156.48M-77.61M
FY200731 Dec 200760.36M-37.56%78.68M-18.32M
FY200631 Dec 200696.67M-27.17%7.13M89.54M
FY200531 Dec 2005132.73M-3.31%551.00K132.18M
FY200431 Dec 2004137.27M-37.80%1.81M135.46M
FY200331 Dec 2003220.71M+49.94%1.28M219.43M
FY200231 Dec 2002147.19M+85.01%1.02M146.17M
FY200131 Dec 200179.56M+5.79%8.38M71.18M
FY200031 Dec 200075.20M+28.33%8.47M66.73M
FY199931 Dec 199958.60M-46.29%3.84M54.76M
FY199831 Dec 1998109.10M+1.96%9.40M99.70M
FY199731 Dec 1997107.00M-16.21%4.10M102.90M
FY199631 Dec 1996127.70M-14.47%3.00M124.70M
FY199531 Dec 1995149.30M+492.46%1.70M147.60M
FY199431 Dec 199425.20M+33.33%0.0025.20M
FY199331 Dec 199318.90M+9.88%0.0018.90M
FY199231 Dec 199217.20M+84.95%0.0017.20M
FY199131 Dec 19919.30M—0.009.30M

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Total debt,Free cash flow,Stock buybacks,Balance sheet

Common questions about IDEXX Laboratories's cash

Source: Financial Modeling Prep